BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Nottingham's SIAM & IMA Student Chapter - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:University of Nottingham's SIAM & IMA Student Chapter
X-ORIGINAL-URL:https://nottingham-siam-ima.com
X-WR-CALDESC:Events for University of Nottingham's SIAM & IMA Student Chapter
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260204T130000
DTEND;TZID=UTC:20260204T140000
DTSTAMP:20260417T050314
CREATED:20260112T191031Z
LAST-MODIFIED:20260302T114709Z
UID:706-1770210000-1770213600@nottingham-siam-ima.com
SUMMARY:Mathematics in Drug Development with Linnéa Franssen
DESCRIPTION:Linnéa Franssen\, Principal Modeling and Simulation Scientist at Roche\, is joining us to share personal reflections and suggestions regarding opportunities to enter the pharmaceutical industry from academia as a modeller. \n\n\n\nLinnéa holds a PhD in Mathematical Oncology from the University of St Andrews\, following an MSci in Mathematics at the University of Glasgow. She joined Roche as a Postdoc in 2020\, where she developed approaches to predict immunogenicity of therapeutic proteins. Transitioning to a permanent Scientist position in 2022\, she supports protein therapeutic drug development through model-based predictions that e.g. support the optimization of drug dosing schedules for First-in Human dosing or enable selecting lead drug candidates. \n\n\n\nLinkedIn post of the event: https://tinyurl.com/5xwmh5y6
URL:https://nottingham-siam-ima.com/event/mathematics-in-drug-development-with-linnea-franssen/
END:VEVENT
END:VCALENDAR